U.S. Secretary of Energy Rick Perry and Lithuanian Minister of Energy Zygimantas Vaiciunas attend a news conference after the partnership for Transatlantic energy cooperation conference in Vilnius, Lithuania October 7, 2019. REUTERS/Ints Kalnins VILNIUS (Reuters) – U.S. Energy Secretary Rick Perry said on Monday he had no plans to resign now or next month, denying
0 Comments
LONDON (Reuters) – Thousands of climate-change protesters took to the streets in cities around the world on Monday, launching two weeks of peaceful civil disobedience to demand immediate action to cut carbon emissions and avert an ecological disaster. In London, police arrested 217 activists from the Extinction Rebellion group as they blocked bridges and roads
0 Comments
NEW YORK (Reuters) – A federal judge on Monday said eight years of U.S. President Donald Trump’s tax returns must be provided to Manhattan prosecutors, forcefully rejecting the president’s argument that he was immune from criminal investigations. Trump’s returns will not be turned over immediately, after the 2nd U.S. Circuit Court of Appeals in Manhattan
0 Comments
WASHINGTON/SHANGHAI (Reuters) – An increasing number of U.S. lawmakers voiced anger on Monday over the NBA’s response to a Houston Rockets official’s tweet backing Hong Kong democracy protests, raising U.S.-China tensions as talks to end a 15-month trade war resumed. The National Basketball Association, which has built a huge following and burgeoning business in China,
0 Comments
An activist holds a sign as he stands on the roof of a car during the Extinction Rebellion protest at Trafalgar Square in London, Britain October 7, 2019. REUTERS/Marika Kochiashvili LONDON (Reuters) – London’s Metropolitan Police said on Monday it had so far arrested 267 people taking part in demonstrations organised by the climate change
0 Comments
(Reuters) – The U.S. Food and Drug Administration on Monday approved a bone-building drug from Pfenex Inc to treat osteoporosis in certain patients at high risk for fractures, giving the company its first commercial product. The company said it is seeking the FDA’s authorization to designate the drug, PF708, as therapeutically equivalent to Eli Lilly
0 Comments